Procalcitonin for guidance of antibiotic therapy

The Value of Serum Procalcitonin Level for Differentiation of Infectious from Noninfectious Causes of Fever After Orthopaedic Surgery

(2010) Sabina Hunziker et al.   JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME

Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial

(2010) Lila Bouadma et al.   LANCET

Long-term stability of procalcitonin in frozen samples and comparison of Kryptor® and VIDAS® automated immunoassays

(2009) Philipp Schuetz et al.   CLINICAL BIOCHEMISTRY

Comparison of a New Procalcitonin Assay from Roche with the Established Method on the Brahms Kryptor

(2009) H. K. de Wolf et al.   CLINICAL CHEMISTRY

Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission—a randomized trial

(2009) K.B. Kristoffersen et al.   CLINICAL MICROBIOLOGY AND INFECTION

Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a post-study survey

(2009) P. Schuetz et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study

(2009) D. Stolz et al.   EUROPEAN RESPIRATORY JOURNAL

Correlation between antibiotic use and resistance in a hospital: Temporary and ward-specific observations

(2009) I. Willemsen et al.   INFECTION

Effect of Procalcitonin-Based Guidelines vs Standard Guidelines on Antibiotic Use in Lower Respiratory Tract Infections

(2009) Philipp Schuetz et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Risk Prediction With Procalcitonin and Clinical Rules in Community-Acquired Pneumonia

(2008) David T. Huang et al.   ANNALS OF EMERGENCY MEDICINE

Procalcitonin-Guided Antibiotic Use vs a Standard Approach for Acute Respiratory Tract Infections in Primary Care

(2008) Matthias Briel et al.   ARCHIVES OF INTERNAL MEDICINE

The Procalcitonin And Survival Study (PASS) – A Randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitoninand pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients

(2008) Jens-Ulrik Jensen et al.   BMC INFECTIOUS DISEASES

Prognostic value of procalcitonin in Legionella pneumonia

(2008) J. Haeuptle et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

The Role of Procalcitonin in Febrile Neutropenic Patients: Review of the Literature

(2008) Y. Sakr et al.   INFECTION

Seasonality of Antibiotic‐ResistantStreptococcus pneumoniaeThat Causes Acute Otitis Media: A Clue for an Antibiotic‐Restriction Policy?

(2008) Ron Dagan et al.   JOURNAL OF INFECTIOUS DISEASES

Sepsis: rethinking the approach to clinical research

(2008) John C. Marshall   JOURNAL OF LEUKOCYTE BIOLOGY

Use of Procalcitonin to Shorten Antibiotic Treatment Duration in Septic Patients

(2007) Vandack Nobre et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes

(2007) S. Kruger et al.   EUROPEAN RESPIRATORY JOURNAL